Prochloraz

Prochloraz (CAS No.: 67747-09-5) is a small-molecule imidazole antifungal agent with broad utility in biomedical research due to its multifaceted endocrine-disrupting and enzyme-inhibitory activities. It exerts its primary antifungal effect by inhibiting cytochrome P450-dependent 14α-demethylation of lanosterol, thereby blocking ergosterol biosynthesis and compromising fungal cell membrane integrity, leading to cell death. In mammalian systems, Prochloraz functions as a potent aromatase inhibitor and displays antagonistic activity toward estrogen and androgen receptors, with inhibitory effects generally observed in the low micromolar to submicromolar range, while also acting as an agonist of the aryl hydrocarbon receptor at low micromolar concentrations. These combined activities position Prochloraz as a valuable tool for investigating steroidogenesis, nuclear receptor signaling, and xenobiotic-responsive pathways. In vitro and in vivo studies further demonstrate its capacity to modulate hormone levels and reproductive organ development, supporting its use in endocrine disruption and toxicology research. Prochloraz is commonly applied in cell-based assays and animal models to explore mechanisms of hormone regulation, receptor cross-talk, and antifungal pharmacology, with experimental concentrations or dosing regimens adjusted according to specific study designs.